Your browser doesn't support javascript.
loading
Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.
Grem, J L; Harold, N; Shapiro, J; Bi, D Q; Quinn, M G; Zentko, S; Keith, B; Hamilton, J M; Monahan, B P; Donavan, S; Grollman, F; Morrison, G; Takimoto, C H.
Affiliation
  • Grem JL; Medicine Branch, Division of Clinical Sciences, National Cancer Institute, National Naval Medical Center, Bethesda, MD 20889, USA. jgrem@helix.nih.gov
J Clin Oncol ; 18(23): 3952-63, 2000 Dec 01.
Article in En | MEDLINE | ID: mdl-11099325
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uracil / Antineoplastic Combined Chemotherapy Protocols / Enzyme Inhibitors / Fluorouracil / Neoplasms / Antimetabolites, Antineoplastic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uracil / Antineoplastic Combined Chemotherapy Protocols / Enzyme Inhibitors / Fluorouracil / Neoplasms / Antimetabolites, Antineoplastic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States